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Abstract.  We have constructed a  series of mutations 
in the signal sequence of the yeast vacuolar protein 
carboxypeptidase Y  (CPY), and have used pulse-chase 
radiolabeling and immunoprecipitation to examine the 
in vivo effects of these mutations on the entry of the 
mutant CPY proteins into the secretory pathway. We 
find that introduction of a  negatively charged residue, 
aspartate, into the hydrophobic core of the signal se- 
quence has no apparent effect on signal sequence func- 
tion. In contrast, internal in-frame deletions within the 
signal sequence cause CPY to be synthesized as un- 
glycosylated precursors.  These are slowly and ineffi- 
ciently converted to glycosylated precursors that are 
indistinguishable from the glycosylated forms pro- 
duced from the wild-type gene. These precursors are 
converted to active CPY in a PEP4-dependent manner, 
indicating that they are correctly localized to the vacu- 
ole. Surprisingly, a  deletion mutation that removes the 
entire CPY signal sequence has a  similar effect: un- 
glycosylated precursor accumulates in cells carrying 
this mutant gene, and >10%  of it is posttranslationally 
glycosylated. Thus, the amino-terminal signal se- 
quence of CPY,  while important for translocation 
efficiency, is not absolutely required for the transloca- 
tion of this protein. 
S 
ECRETORY proteins (3), many membrane proteins (2, 
18), and the proteins of intracellular organelles such 
as  the  lysosome (8)  are  synthesized by membrane- 
bound ribosomes on the rough endoplasmic reticulum (ER).I 
Here the nascent proteins are transported across or inserted 
into the membrane. The signal hypothesis (3) is a commonly 
accepted model for the mechanism by which the cell directs 
these proteins to the ER. According to the signal hypothesis, 
the proteins  are  synthesized with hydrophobic amino-ter- 
minal extensions,  15-30  amino acids in length, known as 
secretory signal sequences or signal peptides. The signal se- 
quences allow signal recognition particle to recognize the 
translation complexes synthesizing these proteins (45) and to 
mediate the binding of the polysomes to the ER membrane 
via the signal recognition particle receptor (10, 26). After the 
polysomes have bound to the membrane, the growing poly- 
peptide chains are cotranslationally translocated across the 
membrane  (45).  During  translocation,  most  signal  se- 
quences are removed by signal peptidase (3), and the core 
carbohydrate units  of asparagine-linked glycosylation are 
added to the protein (19, 32). Prokaryotes are thought to use 
a similar system to direct proteins through their cell mem- 
branes (39). 
The amino acid sequences of secretory signal peptides 
vary widely, but they have some common features. Usually 
1. Abbreviations  used in this paper: CPY, carboxypeptidase Y; ER, endo- 
plasmic reticulum; preproCPY, unglycosylated CPY precursor with signal 
sequence attached; proCPY, precursor  form of CPY; uproCPY, unglyco- 
sylated precursor form of CPY. 
one or more basic amino acids are found near the amino ter- 
minus of the signal sequence,  followed by a  hydrophobic 
"core" region (44).  The carboxy-terminal end of the signal 
sequence is less hydrophobic and generally contains a signal 
peptidase cleavage site (43).  Mutational analysis has shown 
that point mutations and  small deletions in a  number of 
prokaryotic signal sequences can prevent or reduce translo- 
cation of the proteins (reviewed in reference 39). In contrast 
to the results with prokaryotes, recent studies of the yeast in- 
vertase signal sequence have shown that the yeast transloca- 
tion apparatus can tolerate  ~  substantial deletion, substitution, 
and insertion mutations in that signal sequence (4, 16). How- 
ever, if the deletions or substitutions are made large enough, 
translocation is prevented and the mutant invertase accumu- 
lates in the cytoplasm (16, 29). This greater sequence flexibil- 
ity might be a unique property of the yeast invertase signal 
sequence, or it might be a general feature of  eukaryotic signal 
sequences. 
To learn more about the structural requirements for eu- 
karyotic signal sequences we have constructed a  series of 
mutations in the signal sequence of the yeast vacuolar en- 
zyme, carboxypeptidase Y (CPY). CPY is a protein of the 
vacuole, the yeast cell's equivalent of a lysosome. It is synthe- 
sized on ER-bound ribosomes as an inactive glycosylated 
precursor (proCPY) (27, 40). It was previously believed that 
the CPY signal sequence was not removed during transloca- 
tion (6).  We present evidence that it is removed by signal 
peptidase. From the ER, proCPY is transported to the Golgi 
apparatus, where its carbohydrate is further elaborated, be- 
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at the vacuole, proCPY is proteolytically cleaved to its ma- 
ture, active form (6, 40). In this report we describe the effects 
of mutations in the CPY signal sequence. We show that these 
mutations  decrease the  efficiency of translocation of CPY 
across the ER membrane, and that the mutant forms of CPY 
appear to be posttranslationally translocated. In addition, we 
show that a mutant form of CPY that entirely lacks its amino- 
terminal signal sequence can nevertheless be translocated in 
vivo with >10%  efficiency. 
Materials and Methods 
Strains, Growth Conditions, and Materials 
Saccharomyces  cerevisiae  strain  SEY2202  (MATer  ura3-52,  1eu2-3,112, 
his4-519) was obtained from S.  Emr (California Institute of Technology, 
Pasadena, CA). A chromosomal deletion of  the PRC1 gene in this strain was 
constructed as described previously (41) to form SEY2202-prcl-A2::LEU2. 
EBY14-11C (MATa ura3-52, 1eu2-3,112, his3-A200,  lys2-801,  prcl-A3::H1S3) 
was constructed by standard genetic crosses. The prcl-A2::LEU2 deletion 
removes a large section of the coding region of the PRC1 gene (Barn HI to 
Barn HI; reference  41 and Fig. l), while theprcl-A3::H1S3 deletion removes 
this region and also the Sst II to Barn HI fragment, which includes the initia- 
tion codon and signal sequence coding region. A pep4A version of EBYI4- 
11C was constructed by gene transplacement (34)  as previously described 
(1). Escherichia  coli strain JMI01  is supE,  thi, A(lac-proAB), [F', traD36, 
proaB,  lacl  q ZAM15]  (47).  g.  coli  strain  MC1061 (F-  hsdR-  hsdM  + 
araD139 (araABOIC-leu) 7679A(lac)X74  galU galK rpsL) was provided by 
S. Emr, as was plasmid pSEYS. 
Yeast cultures were grown with shaking at 30 ° in MV-pro liquid media 
(which contains 1% proline as nitrogen source) (41) supplemented with the 
appropriate nutrients and 50 mM potassium phosphate, pH 5.7. 
Restriction enzymes, T4 DNA ligase, Klenow fragment of DNA poly- 
merase, synthetic linkers, and DNA sequencing primers were from New 
England  Biolabs  (Beverly,  MA)  or  Bethesda  Research  Laboratories 
(Gaithersburg, MD). Nuclease Ba131 was from Bethesda Research Labora- 
tories. Antibody to CPY has been described previously (40). Carrier-free 
35S-H280,I was from ICN (Irvine, CA). Translation grade [35S]methionine 
was from New England Nuclear (Boston, MA).  esI protein A  was from 
Amersham Corp. (Arlington Heights, IL). Fraction II lyticase was prepared 
as  described previously  (37).  Endoglycosidase F  was  from  Boehringer 
Mannheim Biochemicals (Indianapolis, IN).  Concanavalin A  Sepharose, 
Percoll, cycloheximide, and substrates for enzyme assays were purchased 
from Sigma Chemical Co.  (St.  Louis,  MO).  DE-52  cellulose was from 
Whatman (Maidstone, Kent, United Kingdom). 
Isolation of  proCPY  from Culture Medium 
S. cerevisiae strain EBYI4-11C-Apep4 transformed with the multicopy PRC] 
plasmid pEBY6  was  grown to  a  cell density of  1.5  A~0  (~1.5  x  107 
cells/ml) in  1 liter of MV-pro media containing 50 mM potassium phos- 
phate, pH 6.5. During the last cell doubling, the pH was monitored and ad- 
justed upward  with 0.1  M  NaOH  if it fell below 5.7. The medium was 
clarified by centrifugation followed by filtration through a 1.2-1~m  Millipore 
filter.  It was then adjusted to pH 6.0, 0.1 IxM pepstatin, 2 mM EDTA, and 
1 mM phenylmethylsulfonyl fluoride, and chilled to 4°C. The medium was 
mixed with  10 ml (settled volume) of DE-52 cellulose equilibrated with 
buffer A (20 mM Tris HC1, pH 7.0, 2 mM EDTA, 0.1 ~  pepstatin, 1 mM 
phenylmethylsulfonyl  fluoride) and stirred at 4°C for I h. The resin was col- 
lected in a sintered glass funnel, washed with several volumes of buffer A, 
and transferred to a chromatography column. The proCPY was eluted with 
400 mM NaC1 in buffer A. Fractions were monitored for the presence of 
proCPY by SDS PAGE followed  by Coomassie Blue staining and/or Western 
blotting. Fractions containing proCPY were pooled, concentrated using a 
Centricon filter concentrator (Amicon Corp., Danvers, MA), lyophilized, 
and stored at  -20°C until use. 
Amino-terminal sequence analysis of proCPY was  performed by the 
University of Oregon Biotechnology Laboratory on a gas-phase protein se- 
quencer (model 470A; Applied Biosystems, Foster City, CA) using Edman 
degradation chemistry (7). 
Plasmid Constructions and Recombinant 
DNA Techniques 
Restriction endonuclease digestions and ligations with T4 DNA ligase were 
performed as recommended by the suppliers. Plasmid purification, agarose 
gel electrophoresis, and DNA-mediated transformations ofE. coli were per- 
formed according to standard methods (25). E. coli strain MCI061  was used 
for all plasmid manipulations and JM101 was used for M13 phage wark. 
DNA sequencing was performed by the chain termination method of  Sanger 
et al. (35) using the MI3mpl8 and mpl9 vectors (47). Plasmids were intro- 
duced into yeast cells using the lithium acetate transformation method (14). 
pTSY1005 was constructed by inserting the C/a I to Hind III fragment of 
the PRC1 gene (41), with an Eco RI linker at the C/a I site, into the polylinker 
of a single-copy URA3 centromere plasmid (see Fig. 1 for a restriction map 
of PRC1 ). pEBX is the Eco RI to Pvu 11 PRCI fragment of pTSYI005  sub- 
cloned into pBR322 between Eco RI and Nde I after filling in the Nde I site. 
pEBY6 is the Eco RI to Hind FII fragment of pTSYI005  subcloned into the 
polylinker of the multicopy (2 ~tm) URA3 vector pSEY8 (36). To construct 
theprcl-A2-28 mutation, pEBX was cut with Acc I and Xba I, the ends were 
filled in with Klenow fragment of DNA polymerase, and  Cla  I  linkers 
(CATCGATG) were inserted to provide an in-frame ATG adjacent to codon 
28 of the PRC1 coding region. The sequence at the deletion junction was 
determined by DNA sequencing and the mutation was subcloned into yeast 
vectors pTSY1005 and pEBY6. 
Oligonncleotide-directed  mntagenesis was used to introduce a glycine to 
aspartic acid mutation at codon 12 of the PRC1 gene. A mutagenic primer, 
5AGTGGACAGATCTAGTCCAC3' synthesized by the triester method (13), 
was  used to prime  second-strand synthesis in  M13mpl8  by  the double- 
primer method (48). The resulting double-stranded DNA was cut with Stu I 
to destroy nonmutagenized DNA and then used to transfect E. coli JM101. 
Transfectants were screened by restriction mapping (the mutagenesis con- 
verted the Stu I site to a Bgl II site), and several with the expected restriction 
pattern were subjected to DNA sequence analysis. One with the desired se- 
quence was  chosen, and the mutation was  subcloned into yeast vectors 
pTSY1005 and pEBY6. 
Deletions at the unique Stu I site of pEBX were constructed using exo- 
nuclease Ba131 according to the method of Maniatis et al. (25). The deleted 
plasmids were recircularized by ligation and amplified in E. coli. Then the 
Eco RI to Bgl II fragments from the resulting library were subcloned into 
the multicopy plasmid pEBY6 and again amplified in E.  coli before being 
introduced into yeast. 
For hydroxylamine mutagenesis, pEBX was treated with 0.4 M hydrox- 
ylamine in 0.1 M sodium phosphate at pH 6.0 for 12 h at 75°C. After ethanol 
Ace  I  Xba  I 
M  K  A  F  T  S  L  L  C  G  L  G  L  S  T  Y  L  A  K  A  I  $  L  Q  R  P  L  G  L  D 
B  PH 
I  I  I  I  I 
Ss  Bo  Bo 
,  > 
I.Okb 
I  I 
Figure 1. Restriction map of PRC1 subclone 
used  for  transformation  and  mutagenesis. 
Open  arrow  indicates  protein  coding  re- 
gion.  A, Acc I;  B, Bgl II; Ba, Barn HI;  C, 
Cla I; H, Hind III; P, Pvu II; R, Eco RI; S, 
Stu I;  Ss, Sst II;  X, Xba I. 
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ing Stu I-resistant 95-bp Acc I to Xba I fragment was subcloned into un- 
mutagenized pEBX. The resulting library of mutagenized plasmids was am- 
plified in E.  coli,  and its Eco RI to Bgl II fragment was subcloned into 
pEBY6,  followed by a second amplification in E. coli. 
Screening for Signal Sequence Mutants 
Libraries of mutagenized PRC1 genes in the multicopy plasmid pEBY6 were 
introduced into  S.  cerevisiae  SEY2202-prcl-A2::LEU2.  URA3 transfor- 
mants were patched onto MV-pro plates and tested by CPY filter assay (33). 
Transformants that failed to produce a pink patch (indicative of CPY secre- 
tion) were further screened by Western blotting. Transformed cells were 
grown in MV-pro liquid to an A~o of 0.5-2.0.  Three A~0 units of cells 
were washed with l0 mM Tris-HCl, pH 8.0,  1 mM EDTA and then taken 
up in 40 p.1 of SDS sample buffer (50 mM Tris-HCl, pH 6.8, 10% glycerol, 
2%  SDS, 2%  2-mercaptoethanol) and heated in a boiling water bath for 
3 min. The extracts were centrifuged for 2 min in a microfuge and the super- 
natants were subjected to SDS PAGE (40). The gels were electroblotted onto 
nitrocellulose membranes in a Trans-blot apparatus (Bio-Rad Laboratories, 
Richmond, CA) and developed with CPY antibody using an Immuno Blot 
assay kit (Bio-Rad Laboratories) following the manufacturer's instructions 
as modified by Ammerer et al. (1). Transformants that produced a 59-kD 
form of CPY (the expected size for unglycosylated proCPY) were studied 
further by immunoprecipitation and plasmid mapping. 
Radiolabeling, Immunoprecipitation, and 
Associated Techniques 
Radiolabeling, endoglycosidase  F treatment, and immunoprecipitation were 
performed as described previously (1, 41) except that chases contained a 
final concentration of 1 mM cysteine, 1 mM methionine, and 0.1 mg/ml cy- 
cloheximide in addition Io  10 mM Na2SO4. The level of 3~S obtained in 
cell extracts remained constant during chases for at least 2 h. Glycosylated 
and unglycosylated forms of CPY were fractionated with concanavalin A 
Sepharose by the procedure of Ferro-Novick et al. (9). SDS polyacrylamide 
gels (21) were loaded with aliquots of immunoprecipitated CPY represent- 
ing equal amounts of 3sS counts per minute incorporated. In vitro trans- 
lation was performed using a rabbit reticulocyte lysate kit from Promega 
Biotec (Madison, WI), according to the manufacturer's instructions. Fluo- 
rograms were quantitated by densitometric scanning using a laser scanning 
densitometer  (model SL-5040-XL; Biomed Instruments, Fullermn, CA). To 
determine the percent glycosylation of the mutant forms of CPY, the total 
amount of glycosylated proCPY seen after a 2-h chase was divided by the 
amount of unglycosylated proCPY produced during the 5-min pulse: per- 
cent glycosylated =  (glycosylated [2 h])/(unglycosylated [pulse])  x  100. 
Enzyme Assays and Percoll Gradient 
Total CPY activity was determined as described previously (40) on extracts 
prepared by glass bead lysis (1). Protein was determined by the method of 
Lowry et al.  (24).  NADPH cytochrome c  reductase was assayed as de- 
scribed previously (20).  Glucose-6-phosphate dehydrogenase was assayed 
by the method of Lohr and Waller (22) and vanadate-sensitive ATPase was 
assayed by the method of Ohnishi et al. (28). Percoll gradient fractionation 
of yeast membranes was performed by the method of Hansen et al. (12), but 
without protease inhibitors. 
Results 
The CPY Signal Sequence Is Cleaved 
Previous work suggested that the CPY signal sequence was 
not cleaved, since the in vitro translation product of  the PRC1 
gene (preproCPY)  comigrated on SDS  gels with the un- 
glycosylated proCPY (uproCPY) synthesized in vivo in the 
presence of tunicamycin (6).  We repeated this experiment 
and found that the two polypeptides also comigrated in our 
hands, both on 8% polyacrylamide SDS gels and on 5-15% 
polyacrylamide  gradient SDS gels (not shown). However, we 
also found that mutant forms of proCPY from PRC1 deletion 
mutants lacking 5-27 amino acids near the amino terminus 
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Figure 2.  Amino-terminal amino acid sequences of preproCPY 
deduced from the DNA sequence (top) and proCPY as determined 
by amino-terminal amino acid analysis (bottom). 
of preproCPY (see below) all comigrated with each other 
and with in vitro translated wild-type preproCPY (data not 
shown). We conclude from this that SDS gels are not useful 
for assessing the cleavage of the CPY signal peptide. 
We turned to amino-terminal analysis as a  more direct 
method for determining whether the CPY signal sequence 
was removed. When CPY is overproduced from a multicopy 
(2 lxm) plasmid, approximately half of the proCPY synthe- 
sized is secreted to the cell surface instead of being delivered 
to the vacuole (41). We took advantage of this observation to 
purify proCPY from the culture media of cells containing 
such a plasmid, as described in Materials and Methods. We 
subjected this protein to amino-terminal sequence analysis 
and compared the resulting sequence with the amino acid se- 
quence deduced from the DNA sequence (42).  The results 
are shown in Fig. 2. The first amino acid of the proCPY pro- 
tein is amino acid 21 of the deduced amino acid sequence. 
This amino terminus probably results from the cleavage of 
the initial translation product of the PRC1 gene by signal pep- 
tidase, since the cleavage site obeys the "minus 1, minus 3" 
rule, with both residues (-3 and -1) being alanine (43). 
Introduction of  a Negative Charge into 
the Signal Sequence 
A common feature of nearly all eukaryotic and prokaryotic 
signal sequences is a core region of 7-20 hydrophobic amino 
acids (44). The CPY signal sequence contains such a hydro- 
phobic region (amino acids 3-18, Fig. 3). We reasoned that 
if hydrophobicity of this region were important for signal se- 
quence function, introduction of a charged amino acid into 
this core should disrupt this function. Similar mutations have 
previously been shown to interfere with the function of pro- 
karyotic signal sequences (39).  To test this hypothesis, we 
used  oligonucleotide-directed mutagenesis  to  replace  the 
GGC codon encoding glycine 12 of the signal sequence with 
GAT, encoding aspartic acid (Fig. 3, line 2). This sequence 
change created a Bgl II restriction site that was easily fol- 
lowed during subsequent DNA manipulations. 
When this new allele (PRC1-Asp12) was introduced into 
yeast cells on a centromere plasmid or a multicopy plasmid, 
the resulting transformants were indistinguishable from cells 
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wtldtype  MKAFTSLtCGLGLSTTLAKAISLQRPLGLDKDVLLQAAEKFGLDL 
~pl2  NKAFTSLLCGLDLSTTLAKAISLQRPLGLOKDVLLQAAEKFGLDL 
~8-12  NKAFTSLL  .....  STTLAKAtSL~RPLGLOK~YLLQAAEKF~LOL 
~7-12  RKAFTSL  ......  STTLAKAISLQRPLGLDKDVLLQAAEKFGLDL 
A13-23  MKAFTSLLCGLG  ...........  QRPLGLOKOVLLQAAEKFGLDL 
a9-29  MKAFTSLL  .....................  DKDVLLQAAEKFGLDL 
AZ-28  M ...........................  LDKDVLLQAAEKFGLOL 
Figure ~ Amino-terminal sequences of wild-type preproCPY and 
signal sequence mutant, deduced from DNA sequence analysis. 
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CPY activity 
PRCI allele  PEP4  pep4A 
mU/mg  mU/mg 
wild type  0.68  0.01 
Aspl2  0.70  0.01 
A8-12  0.08  0.01 
A7-12  0.03  0.01 
A13-23  0.03  0.01 
A9-29  0.02  0.01 
A2-28  0.01  0.01 
Aprcl  0.0l  0.01 
EBYI4-11C cells (PEP4  or pep4A) carrying the indicated PRC1 allele on a 
multicopy plasmid  were broken with glass beads to prepare a lysate and as- 
sayed for CPY activity  and total protein  as described  in Materials  and Methods. 
CPY activity is expressed as milliunits of activity in cleaving N-benzoyl-L- 
tyrosine p-nitroanilide per milligram  protein. 
teria. The level of CPY activity in the mutant was the same 
as the CPY activity of wild-type transformants (Table I). In 
addition, pulse-chase radiolabeling experiments showed the 
same quantity and forms of CPY antigen present in the mu- 
tants as in transformants with wild-type plasmids (Fig. 4 A, 
compare wild type with Aspl2), and the kinetics of conver- 
sion of precursors to mature CPY were similar for PRC1- 
Aspl2 and wild-type CPY proteins (not shown). 
Construction of Deletion Mutations 
Since introduction of a charged amino acid had no detectable 
effect on  signal  sequence  function,  we  turned  to  deletion 
mutagenesis to produce CPY signal sequence mutations. The 
observation that, when overproduced, proCPY is secreted to 
the cell surface and activated there by a periplasmic activity 
(41) allowed us to devise a screen for detecting mutants that 
failed to translocate proCPY. Secreted CPY activity can be 
detected by a filter assay in which patches of yeast cells are 
transferred to a  filter paper disk containing a chromogenic 
substrate mixture. A pink spot appears on the filter if CPY 
activity is present at the cell surface (33). We reasoned that 
mutations  that  interfered  with  translocation  of  proCPY 
should reduce or prevent secretion of overproduced CPY to 
the cell surface, and should thus prevent the appearance of 
a  pink spot in the filter assay. 
We used nuclease Bal31 to construct a library of mutant 
multicopy plasmids with deletions in the signal sequence re- 
gion of the PRCI gene (at the Stu I  site, see Fig.  1), as de- 
scribed in Materials and Methods.  We then introduced the 
mutagenized plasmid into S. cerevisiae strain SEY2202-prcl- 
A2: :LEU2, which carries a chromosomal deletion mutation 
removing most of the protein-coding portion of the PRC1 
gene. Transformants were screened for CPY secretion by the 
filter assay. Those that gave negative filter assay results were 
analyzed by Western blotting, using CPY antibody as probe. 
This allowed us to discard transformants containing plasmids 
with frameshift and nonsense mutations because these made 
no CPY. It also enabled us to identify signal sequence mu- 
tants by the presence of uproCPY.  Plasmids directing  the 
synthesis of uproCPY were further characterized by restric- 
tion mapping. Several of them were found to contain small 
deletions in the region encoding the CPY signal sequence. 
Three deletions of various sizes (A8-12, A7-12, and A13-23, 
Fig. 3) were chosen for further study. Mutant A9-29 was iso- 
lated by using the same screening method on plasmids that 
had been mutagenized with hydroxylamine. A fifth deletion 
mutation (A2-28) was constructed by deleting the restriction 
fragment  between  Ace  I  (10  nucleotides  upstream  of the 
initiating ATG) and Xba I and inserting a C/a I linker to pro- 
vide an in-frame initiation codon. 
The extent of the deletion mutations was determined by 
DNA sequencing. The deduced amino acid sequences of the 
mutant regions are shown in Fig.  3.  The deletions range in 
size from 5-27 codons and all remove at least a portion of 
the hydrophobic core region of the signal sequence. No new 
amino acids are introduced at the deletion endpoints in any 
of these mutations. 
CPY  Activity of  Signal Sequence Mutants 
All of the deletion mutants displayed reduced CPY activity 
(Table I) and reduced steady-state levels of CPY antigen rela- 
tive to wild type, as detected by Western blotting (data not 
shown). Mutants with large deletions had lower activity than 
mutants with smaller deletions.  When multicopy plasmids 
containing PRC1 signal sequence mutations were introduced 
into EBY14-11C, CPY activity above background level could 
be detected in yeast cell lysates for all mutants except A2-28. 
The  strain  EBY14-11C was  used  for  this  and  subsequent 
studies because it contains a chromosomal deletion remov- 
ing the PRC1 initiation codon and signal sequence as well as 
the internal coding region of the gene. Thus, in this strain, 
the mutant plasmids could not regain a functional signal se- 
quence by gene conversion from the chromsome. 
CPY must be proteolytically cleaved to release the active 
enzyme from the inactive zymogen, proCPY. This activation 
occurs upon or immediately before delivery of proCPY to 
the vacuole and requires the presence of the wild-type PEP4 
gene product (6, 40). If the active CPY produced in the sig- 
nal sequence mutants also depended on the PEP4 gene for 
activation, this would imply that it was correctly transported 
to the vacuole. To determine whether this was the case, we 
Figure 4. uproCPY chases to gly- 
cosylated  proCPY  in  signal se- 
quence deletion mutants. EBY14- 
llC-pep4A was transformed with 
multicopy plasmids containing the 
wild-type  PRC1 gene  or  PRC1 
signal sequence mutant genes as 
indicated. Cultures were pulse-la- 
beled for 5 min with 35S-H2SO4 and analyzed immediately or chased for 2 h in the presence of unlabeled NaESO4, cysteine, methionine, 
and cycloheximide. Labeled cells were collected and converted to spheroplasts. Periplasm and culture medium were pooled to make extracel- 
lular fractions (E), spheroplasts were lysed to make intracellular fractions (I), and CPY was immunoprecipitated from both.  pl, 67-kD 
glycosylated proCPY; p2, 69-kD glycosylated proCPY; upro, uproCPY. 
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EBY14-11C-pep4A cells containing the PRC1 gene or theprcl-A8-12 
gene on multicopy plasmids  were labeled for 15 min with 3sS- 
H2SO4 in the presence or absence of tunicamycin, as indicatexl. 
Cells were lysed by breaking with glass beads in 1% SDS and im- 
munoprecipitated with CPY antibody as described in Materials and 
Methods.  Immunoprecipitates  of non-tunicamyein-treated  cells 
were divided and a portion was treated with endoglycosidase E as 
indicated, to remove asparagine-linked carbohydrate. 
used gene transplacement (34) to create a  deletion in the 
PEP4 gene (1) of EBY14-11C, and transformed the resulting 
pep4A strain with the mutant plasmids. The pep4A transfor- 
mants had no detectable internal CPY activity (Table I), indi- 
cating that the mutant forms of CPY precursor were proba- 
bly  using  the  normal  pathway  for  CPY  localization  and 
processing. 
Deletion Mutants Direct Synthesis of uproCPY 
To examine the forms of CPY synthesized from the mutant 
plasmids, we did pulse-chase radiolabeling of the transfor- 
mants,  followed by immunoprecipitation and  SDS  PAGE. 
Fluorograms from such an experiment are shown in Fig. 4. 
In this experiment, cells were pulse-labeled with 35S-H2SO4 
for 5 min, and aliquots were taken immediately and after a 
2-h  chase.  Internal  (spheroplast)  and  external  (periplasm 
plus medium) fractions were immunoprecipitated with CPY 
antiserum. The PRC1 genes were present on multicopy plas- 
mids in this experiment, so it was expected that the resulting 
overproduction of CPY would cause secretion of a portion 
of the protein (41). 
When cells containing the wild-type PRC1 gene on a mul- 
ticopy plasmid are pulse-labeled under these conditions, the 
first CPY antigen seen is the 67-kD "pl" zymogen resulting 
from core-glycosylation  ofproCPY in the ER (Fig. 4 A, wild 
type time zero). The pl  is rapidly converted to the 69-kD 
"p2" form by carbohydrate modifications in the Golgi appara- 
tus (40). In PEP4 cells, the p2 form is converted to the 61-kD 
mature enzyme (the only active form) before or as it arrives 
at the vacuole (6, 40). The experiment shown in Fig. 4 was 
performed using pep4A cells (which accumulate p2 in the 
vacuole) to improve electrophoretic resolution of the glyco- 
sylated and unglycosylated forms of CPY. 
In contrast to the wild-type situation, transformants carry- 
ing signal sequence deletion mutations of PRC1 all produced 
59-kD forms of CPY during pulse-labeling. These polypep- 
tides comigrated with uproCPY made in wild-type and mu- 
tant cells treated with tunicamycin before labeling (Fig. 5 and 
unpublished observation). This indicates that they represent 
full-length, unglycosylated  proCPY. Treatment of the 59-kD 
polypeptides with endoglycosidase F  caused no change in 
their mobility (Fig.  5),  confirming that they contained no 
asparagine-linked carbohydrate. Quantitation of fluorograms 
from three immunoprecipitation experiments, including that 
shown in Fig. 4, showed that the amount of  uproCPY synthe- 
sized during the pulse labeling in the mutants is equivalent 
to  the  amount  of glycosylated proCPY  synthesized  from 
wild-type plasmid, within a factor of two (not shown). This 
indicates that the mutations do not significantly impair tran- 
scription or translation of the PRC1 gene or substantially 
affect plasmid copy number. Similar results were obtained 
when the mutant PRC1 genes were introduced on single copy 
centromere plasmids  (data not shown),  indicating that ac- 
cumulation of uproCPY is not an artifact of overproduction. 
uproCPY Chases to Glycosylated  proCPY 
When PEP4 cells containing theprcl-A8-12,  A7-12, A13-23, 
or A9-29 gene on a mnlticopy plasmid were pulse-labeled 
with  35S-H2SO4 and  chased  in  the presence of cyclohexi- 
mide, CPY antigens corresponding in size to pl and mature 
CPY appeared (Fig. 6 B and data not shown).  These anti- 
gens, like the wild-type forms of CPY, but unlike uproCPY, 
could be precipitated from cell extracts with concanavalin 
A-linked Sepharose (Fig. 6). In addition, they were sensitive 
to endoglycosidase F, and did not appear when the cells were 
pretreated with tunicamycin (data not shown). These results 
indicate that these proteins contain asparagine-linked carbo- 
hydrate. Since we found that under these conditions protein 
synthesis  (and  further synthesis  of CPY)  was  completely 
blocked by cycloheximide during the chase period (data not 
shown), the glycosylated forms of CPY must have been de- 
rived from the uproCPY  that  was  synthesized during the 
pulse labeling.  This  indicates  that  glycosylation occurred 
posttranslationally. PEP4 cells transformed with any of these 
Figure 6.  Concanavalin A frac- 
tionation  of  glycosylated  and 
unglycosylated  forms  of  CPY. 
EBY14-11C (PEP4)  containing the 
(A) wild-type PRC1 gene or (B) 
prd-A8-12  on a multicopy plas- 
mid was pulse-labeled with 35S- 
H2SO4 for 15 min and chased for 
0, 30, or 60 min with unlabeled 
Na2SO4 and cycloheximide.  Cells 
were collec~:l  by centrifugation 
and lysed with glass beads in 1% 
SDS. The lysates were fraction- 
ated with concanavalin A Sepha- 
rose and the fractions immuno- 
precipitated with CPY antibody. 
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tracellularly, whereas both pl  and p2 were seen in pep4A 
ceils. We interpret this to mean that conversion of pl to p2 
is slow, but that p2 is converted to mature CPY in a PEP4- 
dependent manner as rapidly as it is formed. This supports 
our contention that these mutant forms of p2 CPY are deliv- 
ered to the vacuole. 
Although  the  mutants  all  made  approximately  equal 
amounts  of uproCPY  during  a  short  pulse  labeling,  the 
amount ofglycosylated  CPY they produced after a chase var- 
ied from one mutant to another. To quantitate the fraction of 
uproCPY  which eventually became glycosylated, we per- 
formed the pulse-chase radiolabeling experiment shown in 
Fig. 4 and quantitated the bands by microdensitometry. (Ki- 
netic experiments had shown that conversion of uproCPY to 
glycosylated proCPY was maximal after a 2-h chase [our un- 
published observation]). The results of this quantitation are 
presented in Table II. 45 % of the uproCPY made from the 
prcl-A8-12 gene was converted to glycosylated proCPY after 
a 2-h chase, whereas only 7 % of the uproCPY fromprc1-A9- 
29 was glycosylated after such a chase. Intermediate levels 
of posttranslational glycosylation were seen for prcl-A7-12 
and A13-23. No uproCPY remained after a 2-h chase of cells 
containing the PRC1 signal sequence deletion mutant genes. 
Apparently the uproCPY that does not successfully enter the 
secretory pathway is subject to degradation. In general, the 
fraction of each mutant protein undergoing glycosylation fol- 
lows the same pattern as the levels of CPY activity: larger 
deletions lead to less glycosylation. The levels of CPY activ- 
ity in the mutants,  relative to wild type (Table I),  appear 
lower than might be expected from the fraction of uproCPY 
that becomes glycosylated (Table II). However, the numbers 
are not strictly comparable. The rate of delivery of the mu- 
tant CPY proteins to the vacuole is much slower than the 
delivery of wild-type CPY, so that at steady state the mutants 
contain a substantial fraction of their CPY as uproCPY and 
pl. The secretion of a portion of the proCPY in these experi- 
ments is caused by overproduction of the protein from mul- 
ticopy plasmids. When the prcl-A8-12,  A7-12, A13-23,  and 
A9-29 genes were present on single copy centromere plas- 
raids, >90 % of the glycosylated CPY remained intracellular. 
proCPY Translocated without Signal Sequence 
When we constructed a deletion mutation removing the en- 
tire signal sequence of CPY along with eight adjacent amino 
acids (A2-28), we expected this mutant to make only cyto- 
plasmic uproCPY, in analogy to the cytoplasmic form of in- 
vertase made without a signal sequence (5). Remarkably, we 
found that even with  this  deletion mutation,  some glyco- 
sylated proCPY was produced. Fig. 7  shows  the results of 
a pulse-chase radiolabeling experiment with this mutant. In 
this experiment, culture medium, periplasm, and cell lysate 
were immunoprecipitated separately at various timepoints. 
As with the other deletion mutants, uproCPY is seen in the 
cells after a pulse labeling, and glycosylated forms (pl and 
p2) slowly appear during a chase in the presence of cyclo- 
heximide. The pl  and p2 forms were not produced in the 
presence of tunicamycin.  Furthermore, treatment of prc1- 
A2-28 pl  and p2 CPY  with endoglycosidase F  converted 
them to 59-kD uproCPY (data not shown), indicating that 
the protein received normal ER and Golgi carbohydrate addi- 
tions. Quantitation of the A2-28 lanes in Fig. 4 B indicated 
that ,,o12  % of the uproCPY synthesized in this mutant during 
a  5-min pulse labeling was converted to glycosylated pro- 
CPY after a 2-h chase.  As with the other mutants, the re- 
mainder of the uproCPY disappeared during the chase. 
In contrast to the other mutant CPY proteins, which were 
localized to the vacuole, A2-28 proCPY was  secreted into 
the culture medium after receiving Golgi modifications to its 
asparagine-linked carbohydrate chains (conversion to the p2 
form). Apparently none of the proCPY made in this mutant 
reached the vacuole, since the state of the PEP4 gene had no 
effect on the forms of CPY that could be immunoprecipitated 
from cells carrying this mutant gene (data not shown). This 
explains the lack of CPY activity in cells carrying the prc1- 
A2-28  gene.  The  mislocalization is  not  caused  by  over- 
production, since proCPY is also efficiently localized to the 
cell surface in cells carrying a single copy of the prcl-A2-28 
gene on a centromere plasmid (not shown). Vails et al. (42) 
have identified mutations in the PRC1 gene (between codons 
21 and 31) that cause proCPY to be mislocaiized to the cell 
surface. The deletion A2-28 extends into the region that is 
altered in those mislocaiization mutations, providing an ex- 
planation for its effect on CPY localization. We do not yet 
understand why the deletion mutation A9-29, which removes 
this same region of proCPY,  allows proper localization of 
most of that mutant protein to the vacuole. Perhaps the seven 
amino acids of the signal sequence that remain in this con- 
struction can somehow substitute for the normal vacuolar lo- 
calization tag. 
uproCPY Cofractionates with ER Membranes 
In analogy to cytoplasmic invertase (5), prc]-A2-28 upro- 
CPY might be soluble in the cytoplasm because of failure to 
Table IL Giycosylation of  PRC1 Signal Sequence Mutants 
Percent 
PRC1 allele  glycosylation 
wild type  100 
Aspl2  100 
A8-12  45 
A7-12  22 
A13-23  23 
A9-29  7 
A2-28  12 
The gels shown in Fig. 4 were  quantitated  by laser  densitometry.  For the prcl 
mutants, percent  glycosylation  was calculated  as glycosylated  CPY after  2 h/ 
uproCPY after  pulse x  100. 
Figure 7. Glycosylated proCPY is made from a PRC1 gene with no 
signal sequence. EBY14-11C-pep4A  transformed with a multicopy 
plasmid containing the prcl-A2-28  gene was pulse-labeled for 15 
min with 35S-H2SO4 and chased for the indicated times with unla- 
beled NazSO4, cysteine, methionine, and cycloheximide. Intracel- 
lular, periplasmic, and medium fractions (I, P, and M) were im- 
munoprecipitated with  CPY  antibody. The bottom band  in the 
right-hand lane (wild type) is glycosylated mature CPY. 
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be associated with the ER membrane, and stuck at a pre- 
glycosylational stage of translocation. Thus the intracellular 
location of the uproCPY might cast some light on the nature 
of the defect caused by the signal sequence mutations. To ad- 
dress this question, we prepared a lysate of cells containing 
theprcl-A2-28 gene on a multicopy plasmid and fractionated 
it by Percoll gradient centrifugation following the method of 
Hansen et al.  for preparation of ER membranes (12). The 
results of this fractionation are shown in Fig. 8. uproCPY is 
found in the same fractions as NADPH cytochrome c reduc- 
tase, an ER membrane marker (plasma membrane, marked 
by vanadate-sensitive ATPase, is also found in these frac- 
tions),  and does not follow the pattern of a  soluble cyto- 
plasmic enzyme (glucose-6-phosphate dehydrogenase). This 
supports the idea that the uproCPY is associated with mem- 
branes.  If it is membrane-associated, the membrane with 
which it is most likely to be associated is the ER, since a por- 
tion of the uproCPY does eventually enter the ER lumen to 
become glycosylated. 
Discussion 
The 20 amino-terminal amino acid residues of preproCPY 
constitute a  secretory signal sequence. The primary struc- 
ture of this peptide is typical of a signal sequence, and muta- 
tions within the peptide cause substantial reductions in the 
efficiency of translocation of proCPY.  Furthermore, these 
first 20 amino acids  have been found to  support efficient 
translocation of invertase, when substituted for the invertase 
signal sequence (15). When proCPY is overproduced and se- 
creted, its amino terminus corresponds to the expected cleav- 
age site for signal peptidase. While we have not examined 
vacuolar proCPY, Johnson et al.  have found that the CPY 
signal peptide is cleaved in the ER, in proCPY-invertase fu- 
sion proteins (15).  This,  in combination with our results, 
leads  us  to  conclude  that  the  signal  sequence  of native 
preproCPY is cleaved in the ER by signal peptidase. 
We expected that introduction of a charged amino acid res- 
idue into the CPY signal sequence would disrupt the signal 
sequence  function,  since  naturally  occurring  signal  se- 
quences are consistently hydrophobic (44), and prokaryotic 
signal sequences are functionally disrupted by mutations that 
introduce charged residues into them (39). Contrary to our 
expectations, we found that a mutation replacing glycine 12 
(in the center of the CPY signal sequence) with a charged 
aspartic acid residue has no detectable effect on the kinetics 
of translocation,  glycosylation, or transport of the mutant 
protein. This result is in contrast to the results with prokary- 
otes, but is similar to results seen for mutations in another 
eukaryotic signal sequence, that of yeast invertase. Small in- 
sertion, deletion, and substitution mutations in the invertase 
signal sequence have been found to have little effect on the 
translocation of that protein in yeast (4,  16). Furthermore, 
our repeated attempts to generate random point mutations in 
the CPY  signal  sequence (by thionucleotide mutagenesis; 
38) that reduce or eliminate translocation have failed. Taken 
together, these results strongly suggest that eukaryotic signal 
sequences may contain redundant information for recogni- 
tion by the eukaryotic cell's translocation apparatus. 
We have found that deletion mutations that remove five or 
more amino acids of the hydrophobic core of the CPY signal 
Figure 8. Percoll gradient fractionation ofprcl-A2-28 lysate. 1,000 
A60o units of EBY14-11C-Apep4 cells carrying the prcl-A2-28 gene 
on a multicopy plasmid were used to prepare an S-10 lysate (12), 
which was fractionated on a Percoll density gradient (12). The gra- 
dient was collected as 1.4-ml fractions using a gradient fractionater 
(Haake-Buchler, Fort Lee, N  J). Fraction 1 represents the top of the 
gradient. (/bp) 20-1~1  aliquots of  each fraction and of  the S-10  lysate 
(EXT) were subjected to SDS PAGE and Western blotting, using 
CPY antibody and lzsI-protein  A to visualize the CPY bands. (Bot- 
tom) The fractions were also assayed for NADPH cytochrome c 
reductase (o), vanadate-sensitive ATPase (zx), and glucose-6-phos- 
phate dehydrogenate (A) activities. 
sequence interfere with the ability of the protein to be trans- 
located. However, the effect of these mutations is different 
from that of mutations that disrupt invertase signal sequence 
function.  Invertase  mutants  defective in  signal  sequence 
function produce stable cytoplasmic invertase (16). In con- 
trast, the CPY signal sequence mutations described here lead 
to synthesis of unstable uproCPY, a portion of which slowly 
becomes glycosylated and progresses through the secretory 
pathway to the vacuole or the cell surface. Glycosylation of 
uproCPY occurs posttranslationally: it proceeds in the pres- 
ence of cycloheximide, which prevents further synthesis of 
CPY. This may reflect a posttranslational translocation activ- 
ity similar to that seen with a-factor in yeast in vitro transla- 
tion systems (12, 31, 46). Alternatively, full-length uproCPY 
may be  synthesized  in  a  partially  translocated  form that 
slowly becomes accessible to the glycosyl transferases of the 
ER. 
Posttranslational glycosylation has been observed for two 
other proteins entering the secretory pathway in yeast. Mul- 
ticopy plasmid-directed overproduction of either acid phos- 
phatase (U) or killer toxin (23) results in the accumulation 
of the unglycosylated fully translated preproteins in yeast. 
These accumulated preproteins are able to  undergo post- 
translational signal sequence cleavage, asparagine-linked gly- 
cosylation, and subsequent secretion in yeast (11, 23). These 
results gave rise to the view that accumulation of unglyco- 
sylated preprotein is a consequence of overproduction of the 
proteins and  saturation of the ER membrane translocation 
machinery and/or the ER processing machinery (signal pep- 
tidase and glycosyl transferase;  11, 23).  Interestingly, plas- 
mid-directed overproduction of CPY  (,,o1% of total yeast 
protein) does not saturate the ER translocation or processing 
machinery (41, this work). In contrast, the CPY signal se- 
quence mutations lead to the synthesis of  unglycosylated  pro- 
CPY, which only slowly undergoes posttranslational translo- 
cation and/or glycosylation. Therefore, it is clear that the 
yeast secretory pathway is able to carry out posttranslational 
ER processing  (signal  sequence cleavage and  asparagine- 
linked oligosaccharide addition)  and  possibly posttransla- 
Blachly-Dyson and Stevens CPY Can Be Translocated without Signal Sequence  1189 tional translocation for a number of proteins in vivo (11, 23, 
this  work). 
We  have  found  that  the  CPY  signal  sequence  can  be 
grossly altered,  and even removed entirely,  without totally 
abolishing the ability of proCPY to enter the secretory path- 
way. This result appears to contradict  the signal hypothesis. 
There are at least two possible explanations of this phenome- 
non that are not necessarily mutually exclusive. 
First,  it is possible that uproCPY  is intrinsically trans- 
locatable because of some structural feature other than a sig- 
nal  peptide.  For example,  Randall  and  Hardy  have  shown 
that lack of tertiary  structure  appears  to be necessary  for 
translocation of maltose binding protein in E.  coli (30).  If 
lack of proper folding is similarly important  in eukaryotes, 
uproCPY might be susceptible to translocation because of 
failure to fold in the cytoplasm (for instance, folding might 
require  glycosylation  or disulfide  bond  formation,  which 
could only proceed in the ER lumen).  This could explain 
why CPY signal sequence mutants behave differently  than 
invertase  signal  sequence  mutants.  Invertase,  even  with a 
defective signal sequence attached,  folds into an enzymati- 
cally active form in the cytoplasm (16) and this folding might 
prevent  its posttranslational  translocation. 
Alternatively,  it is possible that CPY contains an internal 
signal sequence that can inefficiently direct it to the ER mem- 
brane.  If this is the case, such a sequence cannot readily be 
identified by examining the amino acid sequence of proCPY. 
The amino-terminal signal sequence is the most hydrophobic 
region of the entire preproCPY molecule (data not shown). 
The  propeptide  (amino  acids  21  through  111)  is  highly 
charged (31% charged residues), and the first stretch of more 
than  10 uncharged  amino acids begins at residue  156, well 
within the mature portion of the protein. It might be argued 
that  the  A2-28  deletion  fortuitously  created  a  signal  se- 
quence at the amino terminus of CPY, but, again, examina- 
tion of the amino acid sequence fails to reveal a typical signal 
sequence structure.  On the other hand, naturally  occurring 
signal sequences, on which the model of a consensus signal 
sequence is based, may be much more uniform than is re- 
quired by the cell's translocation apparatus. Kaiser et al. have 
found that •20%  of random  in-frame open reading  frames 
substituted  in place of the invertase  signal sequence could 
support translocation of that protein (17). We are investigat- 
ing the possibility that prc1-A2-28  CPY contains a cryptic 
signal  sequence  by  constructing  further  deletions  in  the 
PRC1 gene to determine whether, by doing so, we can pro- 
duce a form of CPY that remains totally  in the cytoplasm. 
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